
Amyl Therapeutics bags €11m Series A extension
Amyl Therapeutics SA has secured €5m Series A extension from long-term investors Merieux Equity Partners and Noshaq, together with Mr Evren Ucok as a...

Agomab Therapeutics NV raises US$100m in Series C financing
The closed financing round was led by Fidelity Management & Research Company. New investors EQT Life Sciences, Canaan and Dawn Biopharma/KKR, as...

BioSpain breaking records
On its 20th anniversary in Catalonia’s vibrant capital Barcelona, BioSpain 2023 is set to break records in terms of attracting visitors,...

Study links TCM with effects on protein networks
The framework, validated with hospital patient data, is among the first to provide a scientific foundation to evaluate the therapeutic efficacy of...

Majority of EU agri-council supports NGT deregulation
On the occasion of an informal meeting of EU agriculture ministers on NGT plant varieties (3.–5. September), a majority of ministers said they would...

Microharvest GmbH launches SCP-Pilot plant in Lissabon
Prior to its planned product launch of HILIX, a feed product for aquaculture, in early 2024, single-cell protein start-up MicroHarvest GmbH has...

Aboleris Pharma bags €27.3m in Series A Financing
AbolerIS Pharma SA’s financing was led by Caixa Capital Risc and co-led by Sound Bioventures and existing investor Newton Biocapital with...